Related Experiment Video
Updated: Feb 4, 2026

08:42
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
11.6K
Bile acids and their effects on diabetes.
Cynthia Rajani1, Wei Jia2,3
1University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Frontiers of Medicine
|October 12, 2018
Summary
Bile acids (BAs) and their receptors are key targets for managing diabetes and hyperglycemia. Manipulating BAs offers a promising strategy for improving glycemic control and preventing diabetic complications.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Gastroenterology
Background:
- Diabetes mellitus is a growing global health concern characterized by hyperglycemia.
- Poor glycemic control leads to severe vascular complications, including blindness, kidney failure, and cardiovascular events.
- Metabolic memory, a persistent state of metabolic changes, can drive disease progression even after glucose normalization.
Purpose of the Study:
- To review the role of bile acids (BAs) in glucose and lipid metabolism.
- To explore therapeutic strategies targeting BA receptors for glycemic control in diabetes.
- To discuss recent advancements in manipulating the enterohepatic circulation, bariatric surgery, and circadian rhythms for diabetes management.
Main Methods:
- Review of current literature on bile acid signaling pathways.
- Analysis of the function of farnesoid X receptor (FXR) and TGR5 in metabolic regulation.
- Examination of therapeutic interventions involving BA modulation, enterohepatic circulation, and bariatric surgery.
Main Results:
- Bile acids regulate energy metabolism by activating nuclear receptors like FXR and G-protein coupled receptors like TGR5.
- Activation of FXR by BAs influences downstream targets such as FGF15/21, impacting glucose and insulin homeostasis.
- Targeting BA receptors and pathways shows potential for improving glycemic control in diabetic patients.
Conclusions:
- Bile acid metabolism and signaling are critical for maintaining glucose and lipid homeostasis.
- Therapeutic strategies focused on bile acids, their receptors, and related pathways offer novel approaches to diabetes treatment.
- Further research into BA manipulation holds promise for effective diabetes management and prevention of complications.
Related Concept Videos
Substituent Effects on Acidity of Carboxylic Acids
7.9K
The acidity of carboxylic acids is influenced by the nature of the substituents bounded to the functional group. The acid strength is determined by the stability of the carboxylate anion—the conjugate base formed by dissociating the corresponding carboxylic acid.
7.9K
Bile
4.2K
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Bile is released when dietary fats enter...
4.2K
Pathophysiology of Diabetes
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Buffer Effectiveness
55.2K
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised.
The buffer capacity is the amount of acid or base that can be added to a given volume...
The buffer capacity is the amount of acid or base that can be added to a given volume...
55.2K
Nucleic Acids
50.3K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
50.3K
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K

